Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-760-3 | CAS number: 7722-64-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 4.4.-20.4.2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study was carried out in accordance with internationally valid GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Potassium permanganate
- EC Number:
- 231-760-3
- EC Name:
- Potassium permanganate
- Cas Number:
- 7722-64-7
- Molecular formula:
- HMnO4.K
- IUPAC Name:
- potassium manganesoylolate
- Details on test material:
- - Name of test material (as cited in study report): Potassium permanganate
- Molecular formula (if other than submission substance): KMnO4
- Molecular weight (if other than submission substance): 158.03
- Batch No.: 69
- Substance type: technical product
- Physical state: solid crystals
- Analytical purity: 99.42 % wt.
- Impurities (identity and concentrations): Manganese dioxide ca 0.1 % wt.
- Appearance: dark violet-purple crystalline powder with bronze lustre
- pH: 1% solution-6.1
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: breeding farm BioTest s. r. o., Konárovice, 281 25 CZ, Czech Republic
- Weight at study initiation: 199.14 - 318.21 g
- Housing: animal room with monitoring conditions - one animal in one plastic cage
- Bedding: sterilized shavings of soft wood
- Diet: ad libitum; ST 1 BERGMAN - standard pelleted diet ad libitum (producer: Mill Kocannda, Jesenice u Prahy, Czech Republic)
- Water: ad libitum; drinking tap water quality corresponding to Regulation No. 252/2004 Czech. Coll. of Law
- Acclimation period: 15 days
- Randomisation: according to the internal rule, at the start of the study the weight variation of animals was minimal and did not exceed (+/-)
20% of the mean weight for each sex
- Identification of animals: colour marks on tail of animals, each cage was marked with the number of study, number of animals, sex, name and dose of the test substance
- Health condition: certificate of goodhealth condition, no signs of diseases were observed at clinical check-in during the acclimatisation period
and before the start of study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ( +/- )3; permanently monitored
- Humidity (%): 30 - 70 %; permanently monitored
- Air changes (per hr): approximately 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
Study time schedule
Animal supply: 20. 3. 2006
Experimental part of study: 4. 4. – 20. 4. 2006
Evaluation of results and final report elaboration: 21. 4. – 15. 5. 2006
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 6 cm x 6 cm
- % coverage: 10 % of the body surface
- Type of wrap if used: the application site was covered by mull, plastic foil and held in contact by plaster (strapping)
REMOVAL OF TEST SUBSTANCE
- Washing: with water
- Time after start of exposure: 24 hours
TEST MATERIAL
The test substance in delivered form (moistened with the smallest amount of water) was applied on the depilated area of skin.
- Amount(s) applied (volume or weight with unit): 2000 mg/kg
VEHICLE
- Amount(s) applied (volume or weight with unit): no vehicle was used - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg of body weight
- No. of animals per sex per dose:
- 5 female/5 male
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
Body weight recording:
The animals were weighed at the start of the study (before application), at 8th day and in the end of experiment (15th day).
Average body weight in-group was counted from individual body weights. Body weight increments were calculated from body weight at the start of
the study and in the end of the study.
Clinical observation:
After application the animals were observed individually – the first day: twice (30 minutes and 3 hours after application), the second day: twice (in the morning and in the afternoon) and daily thereafter for 14 days.
Observations included changes in skin and fur, eyes, visible mucous membranes, nutritive condition, autonomic and central nervous systems, psychic activity, somatomotor activity, reactions to stimuli, function of respiratory, circulatory, digestive and urogenital system. Also presence of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma was carefully observed.
Pathological examination:
On the 15th day of study all test animals were sacrificed (by injection of veterinary formulation T 61, 1ml/animal) and gross necropsy was carried out.Size, colour, shape, structure and consistency of organs were evaluated. All gross macroscopic changes of organs and tissues were recorded in protocols.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No death of animals was observed during 14 days observation period.
- Clinical signs:
- other: No clinical signs of intoxication of animals were observed. See tables No. 3 and No. 4
- Gross pathology:
- No death of animals was observed during 14 days observation period.
Macroscopic changes were diagnosed during pathological examination in all animals.
See tables No. 5 and No. 6 - Other findings:
- - Organ weights: none
- Histopathology: none
- Potential target organs: none
- Other observations: none
Any other information on results incl. tables
Table No.1: Individual body weight of animals - 2000 mg/kg - males
Animal No. |
Before application |
8th day |
15th day |
Increment |
1 |
294.39 |
321.26 |
376.37 |
81.98 |
2 |
318.21 |
339.30 |
387.66 |
69.45 |
3 |
277.53 |
296.43 |
323.55 |
46.02 |
4 |
269.14 |
291.20 |
339.70 |
70.56 |
5 |
263.13 |
283.25 |
313.62 |
50.49 |
Average |
284.48 |
306.29 |
348.18 |
63.70 |
Table No. 2: Individual body weight of animals - 2000 mg/kg - females
Animal No. |
Before application |
8th day |
15th day |
Increment |
1 |
223.99 |
232.82 |
240.12 |
16.13 |
2 |
199.14 |
204.77 |
221.72 |
22.58 |
3 |
213.85 |
216.47 |
231.97 |
18.12 |
4 |
224.95 |
248.62 |
261.44 |
36.49 |
5 |
208.20 |
224.67 |
237.01 |
28.81 |
Average |
214.03 |
225.47 |
238.45 |
24.42 |
Table No.3: Clinical observations - 2000 mg/kg - males
Animal No. |
Death after application |
Changes |
1 |
no |
No clinical changes |
2 |
no |
No clinical changes |
3 |
no |
No clinical changes |
4 |
no |
No clinical changes |
5 |
no |
No clinical changes |
Table No. 4: Clinical observations - 2000 mg/kg - females
Animal No. |
Death after application |
Changes |
1 |
no |
No clinical changes |
2 |
no |
No clinical changes |
3 |
no |
No clinical changes |
4 |
no |
No clinical changes |
5 |
no |
No clinical changes |
Table No.5: Pathological examination - 2000 mg/kg – males
Animal No. |
Findings |
1 |
Kidney - marked structure |
2 |
Kidney - marked structure |
3 |
Liver – marked structure Kidney - marked structure |
4 |
Kidney - marked structure |
5 |
Kidney - marked structure |
Table No. 6: Pathological examination - 2000 mg/kg – females
Animal No. |
Findings |
1 |
Kidney - marked structure |
2 |
Kidney - marked structure |
3 |
Liver – marked structure Kidney - marked structure |
4 |
Kidney - marked structure |
5 |
Kidney - marked structure |
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The test substance toxicity was evaluated on the basis of mortality, body weight changes, clinical signs of toxicity during the observation period
and necropsy findings in the end of study.
The test substance applied on skin in dose 2000 mg/kg did not cause death of animals. Macroscopic changes were diagnosed during pathological examination in all animals.
No clinical signs of intoxication of animals were observed, but markedly lower body weight gains of females were recorded. - Executive summary:
The test substance Potassium permanganate was tested for the assessment of acute dermal toxicity using Wistar rats.
Testing was performed according to the Method B.3 Acute Toxicity (Dermal), Directive 92/69/EEC. Published in OJ L 383A, 1992.
The study was performed as limit test: two groups of animals – 5 males and 5 females and the dose of 2000 mg/kg. The test substance was applied on the shaved skin of the test animals in delivered form for 24 hours.
The test animals were observed 14 days after application, afterwards were sacrificed and the necropsy for macroscopic examination of the organs was performed.
The test substance applied in dose 2000 mg/kg did not caused death of animals. Macroscopic changes were diagnosed during pathological examination in all animals.
No clinical signs of toxicity were observed during the study in all animals, but markedly lower body weight gains of females were recorded.
According to the results of study the value of LD50 dermal of the test substance Potassium permanganate for rats of both sexes is higher than 2000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.